The first AIDS treatment shows amazing immune responses to humans



[ad_1]

Gulf Monitoring 365 – Asma al-Sayyid – The first experimental AIDS vaccine, known as AIDS, has shown amazing immune responses to humans, according to a scientific study.

The medical journal The Lancet published a study showing that the experimental vaccine, developed by a team of researchers 40 years ago, was starting to show strong reactions, especially in monkeys, and protected them from infection. # 39; infection.

The study showed that the drug appeared to be completely safe in humans, having been tested on approximately 2,600 South African women, who studied the success of the drug to protect them from AIDS.

The medical journal quoted Dan Baroch, Study and Professor at Harvard University: "Although the data is encouraging, we need to be more cautious." "Until now, the vaccine has managed to protect two-thirds of the monkeys in a laboratory experiment, but that does not mean that it will protect humans, so we have to wait for the results of the test." study before knowing if this will protect humans from AIDS ".

The final results of the new AIDS vaccine are expected to occur between 2021 and 2022.

Fortunately, the vaccine has shown "strong immune responses to high levels in humans, which appears to be potentially effective" Ideal for the prevention of AIDS. "

The study indicates that only five participants talked about the side effects of the vaccine, such as abdominal pain, diarrhea, dizziness or back pain.

Thank you for having read the first AIDS treatment that demonstrates incredible immune responses in the Gulf 365 and inform you that the content of the topic was written by beauty magazine and you can read and follow the developments of this news from the source of the link next beauty and we are not responsible for the content of this news with best wishes Happy Day.) d) {var js, id = facebook-jssdk if (d.getElementById (id)) {return } js = d.createElement (& # 39; script & # 39;); js.id = id; js.a sync = true; js.src = "http://connect.facebook.net/ar_AR/all.js#appId=&xfbml=1";d.getElementsByTagName('head')[0].appendChild(js); } (document)); [ad_2]
Source link